Companies: 49,246 Total Market Cap: 132441797263938.02

Dar Al Dawa Development and Investment Co. Ltd.

ASE-DADI
Pharmaceutical Preparations
Rank #27873
Market Cap 59.25 M
Volume 7,182
Price 1.69
Change (%) 0.83%
Country or region Jordan Jordan

Dar Al Dawa Development and Investment Co. Ltd.'s latest marketcap:

59.25 M

As of 05/20/2025, Dar Al Dawa Development and Investment Co. Ltd.'s market capitalization has reached $59.25 M. According to our data, Dar Al Dawa Development and Investment Co. Ltd. is the 27873th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 59.25 M
Revenue (ttm) 116.93 M
Net Income (ttm) 5.20 M
Shares Out 35 M
EPS (ttm) 0.15
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 07/31/2025
Market Cap Chart
Data Updated: 05/20/2025

Dar Al Dawa Development and Investment Co. Ltd.'s yearly market capitalization.

Dar Al Dawa Development and Investment Co. Ltd. has seen its market value grow from د.أ28.75 M to د.أ42 M since 2020, representing a total increase of 46.09% and an annual compound growth rate (CAGR) of 9.03%.
Date Market Cap Change (%)
05/20/2025 د.أ42 M -8.73%
12/31/2024 د.أ44.10 M -4.55%
12/31/2023 د.أ46.20 M 23.36%
12/29/2022 د.أ37.45 M -6.96%
12/30/2021 د.أ40.25 M 40%
12/31/2020 د.أ28.75 M

Company Profile

About Dar Al Dawa Development and Investment Co. Ltd.

Dar Al Dawa Development and Investment Co. Ltd. is a leading integrated pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of pharmaceutical and consumer healthcare products. With a strong presence across multiple regions, the company serves markets in:

  • Levant, Gulf, and Yemen
  • The Middle East
  • Africa
  • Europe
  • Asia

Business Segments

The company operates through two key segments:

  • Medicine: Offers a wide range of pharmaceutical products across various therapeutic areas.
  • Infants’ Cereals and Milk Formula: Provides specialized nutrition products for infants.

Therapeutic Areas

Dar Al Dawa’s pharmaceutical portfolio covers multiple therapeutic categories, including:

  • Anti-infective
  • Cardiovascular and diabetes
  • Urology
  • Respiratory
  • Gastrointestinal
  • Analgesic and musculoskeletal
  • Central nervous system
  • Gynecology
  • Dermatology
  • Ophthalmology
  • Oncology

Company Overview

Founded in 1975, Dar Al Dawa Development and Investment Co. Ltd. is headquartered in Amman, Jordan. The company is committed to serving patients and medical communities with high-quality healthcare solutions.

Frequently Asked Questions

As of 05/20/2025, Dar Al Dawa Development and Investment Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $59.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Dar Al Dawa Development and Investment Co. Ltd. global market capitalization ranking is approximately 27873 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Jordan
Founded 1975
IPO Date n/a
Employees 1,111
CEO Khaled Harb
Sector
Industry Pharmaceutical Preparations
Address P.O Box: 9364
Amman, 11191
Jordan
Website https://www.dadgroup.com
People Also Watch
Ipsen S.A.
138.12 0.83%
Krka, d. d.
209.31 0.83%
BUD-RICHTER
29.06 0.83%
Hugel
244.93 0.83%